1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Cough Drops Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Cough Drops Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Cough Drops Market Regional Analysis
6.2 North America Cough Drops Market Revenue 2021-2031 (US$ Million)
6.3 North America Cough Drops Market Forecast Analysis
7. North America Cough Drops Market Analysis – by Product
7.1 Gluten Free
- 7.1.1 Overview
- 7.1.2 Gluten Free: North America Cough Drops Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Sugar Free
- 7.2.1 Overview
- 7.2.2 Sugar Free: North America Cough Drops Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Others
- 7.3.1 Overview
- 7.3.2 Others: North America Cough Drops Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Cough Drops Market Analysis – by Application
8.1 Adults
- 8.1.1 Overview
- 8.1.2 Adults: North America Cough Drops Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Children
- 8.2.1 Overview
- 8.2.2 Children: North America Cough Drops Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Cough Drops Market Analysis – by Distribution Channel
9.1 Offline
- 9.1.1 Overview
- 9.1.2 Offline: North America Cough Drops Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Online
- 9.2.1 Overview
- 9.2.2 Online: North America Cough Drops Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Cough Drops Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Cough Drops Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 10.2.1.1 North America Cough Drops Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Cough Drops Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 US: North America Cough Drops Market Breakdown, by Product
- 10.2.1.1.2 US: North America Cough Drops Market Breakdown, by Application
- 10.2.1.1.3 US: North America Cough Drops Market Breakdown, by Distribution Channel
- 10.2.1.2 Canada:
North America Cough Drops Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Canada: North America Cough Drops Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Cough Drops Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Cough Drops Market Breakdown, by Distribution Channel
- 10.2.1.3 Mexico:
North America Cough Drops Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Mexico: North America Cough Drops Market Breakdown, by Product
- 10.2.1.3.2 Mexico: North America Cough Drops Market Breakdown, by Application
- 10.2.1.3.3 Mexico: North America Cough Drops Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Bliss GVS Pharma Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Cipla Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Gepach International
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 GSK Plc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Mondelez International Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Reckitt Benckiser Group Plc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Ricola
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Sanofi SA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 The Procter & Gamble Co
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thornton & Ross
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Cough Drops Market
